| Entry |
|
| Name |
Betamethasone acetate and betamethasone sodium phosphate; Celestone soluspan (TN); Rinderon (TN) |
| Product |
|
| Generic |
|
| Component |
Betamethasone acetate [DR: D01402], Betamethasone sodium phosphate [DR: D00972]
|
| Class |
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
| Remark |
| Therapeutic category: | 2454 |
|
| Efficacy |
Anti-inflammatory |
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
| Interaction |
|
| Brite |
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Betamethasone Acetate/ Betamethasone Sodium Phosphate
D04446 Betamethasone acetate and betamethasone sodium phosphate
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
245 Adrenal hormone preparations
2454 Fluorinated adrenocorticotropic hormones
D04446 Betamethasone acetate and betamethasone sodium phosphate
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D04446 Betamethasone acetate and betamethasone sodium phosphate
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04446
|
| Other DBs |
|
| LinkDB |
|